Physician profile
Michael Kirby
NPI 1760429450
$1,115.93
in general payments reported to CMS, 2019-2025
25 companies · $76.95 in 2025
The $76.95 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $130 · 2021: $258 · 2022: $175 · 2023: $18.55 · 2024: $158 · 2025: $76.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $148.47 | 2022-2024 | Qelbree |
| Glaxosmithkline, LLC. | $101.59 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $92.80 | 2019-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Corium, LLC | $87.96 | 2022-2024 | Azstarys |
| Novo Nordisk INC | $77.15 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $70.61 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $60.85 | 2019-2021 | |
| Amgen INC. | $54.66 | 2019-2021 | |
| Dexcom, INC. | $50.81 | 2021 | |
| Ironshore Pharmaceuticals INC. | $50.31 | 2019-2022 | |
| Cranial Technologies, INC | $46.73 | 2019-2025 | Doc Band |
| Sanofi Pasteur INC. | $44.18 | 2019-2022 | |
| Pfizer INC. | $37.75 | 2024 | |
| Collegium Pharmaceutical, INC. | $24.57 | 2025 | Jornay Pm |
| Nestle Healthcare Nutrition INC. | $19.95 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $18.55 | 2023 | Onpattro |
| Orthogenrx INC. | $18.44 | 2019 | |
| Shire North American Group INC | $15.69 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $14.42 | 2019 | |
| Abbott Laboratories | $13.98 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.72 | 2021 | |
| Seqirus USA INC | $13.62 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.19 | 2021 | |
| Horizon Therapeutics Plc | $13.05 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kirby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.